These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29096671)

  • 21. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial.
    Yeboah-Antwi K; Pilingana P; Macleod WB; Semrau K; Siazeele K; Kalesha P; Hamainza B; Seidenberg P; Mazimba A; Sabin L; Kamholz K; Thea DM; Hamer DH
    PLoS Med; 2010 Sep; 7(9):e1000340. PubMed ID: 20877714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon.
    Mombo-Ngoma G; Kleine C; Basra A; Würbel H; Diop DA; Capan M; Adegnika AA; Kurth F; Mordmüller B; Joanny F; Kremsner PG; Ramharter M; Bélard S
    Malar J; 2012 Jul; 11():120. PubMed ID: 22515681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme.
    Landier J; Parker DM; Thu AM; Lwin KM; Delmas G; Nosten FH;
    Lancet; 2018 May; 391(10133):1916-1926. PubMed ID: 29703425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
    Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
    Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
    Katrak S; Gasasira A; Arinaitwe E; Kakuru A; Wanzira H; Bigira V; Sandison TG; Homsy J; Tappero JW; Kamya MR; Dorsey G
    Malar J; 2009 Nov; 8():272. PubMed ID: 19948038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
    Tine RC; Faye B; Ndour CT; Ndiaye JL; Ndiaye M; Bassene C; Magnussen P; Bygbjerg IC; Sylla K; Ndour JD; Gaye O
    Malar J; 2011 Dec; 10():358. PubMed ID: 22166001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Four Rounds of Mass Drug Administration with Dihydroartemisinin-Piperaquine Implemented in Southern Province, Zambia.
    Eisele TP; Bennett A; Silumbe K; Finn TP; Porter TR; Chalwe V; Hamainza B; Moonga H; Kooma E; Chizema Kawesha E; Kamuliwo M; Yukich JO; Keating J; Schneider K; Conner RO; Earle D; Slutsker L; Steketee RW; Miller JM
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):7-18. PubMed ID: 32618247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
    Toure OA; Valecha N; Tshefu AK; Thompson R; Krudsood S; Gaye O; Rao BHK; Sagara I; Bose TK; Mohanty S; Rao BS; Anvikar AR; Mwapasa V; Noedl H; Arora S; Roy A; Iyer SS; Sharma P; Saha N; Jalali RK; ; Tiacoh L; Enosse S; Tangpukdee N; Kokolomami J; Ndiaye JL; Rao D; Yumva NN; Sidibe B; Mohanty R; Jha AC; Nyirenda M; Starzengruber P; Swoboda P
    Clin Infect Dis; 2016 Apr; 62(8):964-971. PubMed ID: 26908796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
    Pareek A; Chandurkar N; Srivastav V; Lakhani J; Karmakar PS; Basu S; Ray A; Pednekar S; Gupta PB; Suthar N; Lakhani S
    Trop Med Int Health; 2013 May; 18(5):578-87. PubMed ID: 23489465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
    Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
    Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
    Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.
    Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Mårtensson A
    Malar J; 2011 Mar; 10():64. PubMed ID: 21410954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.
    Barnes KI; Durrheim DN; Little F; Jackson A; Mehta U; Allen E; Dlamini SS; Tsoka J; Bredenkamp B; Mthembu DJ; White NJ; Sharp BL
    PLoS Med; 2005 Nov; 2(11):e330. PubMed ID: 16187798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.
    Pongvongsa T; Phommasone K; Adhikari B; Henriques G; Chotivanich K; Hanboonkunupakarn B; Mukaka M; Peerawaranun P; von Seidlein L; Day NPJ; White NJ; Dondorp AM; Imwong M; Newton PN; Singhasivanon P; Mayxay M; Pukrittayakamee S
    Malar J; 2018 Nov; 17(1):405. PubMed ID: 30390647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of
    Chishimba S; Mwenda M; Mambwe B; Mulube C; Chalwe V; Moonga H; Hamainza B; Chizema-Kawesha E; Steketee RW; Domingo G; Fraser M; Kahn M; Pal S; Silumbe K; Conner RO; Bennett A; Porter TR; Eisele TP; Miller JM; Bridges DJ
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):82-89. PubMed ID: 32618252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia.
    Okebe J; Dabira E; Jaiteh F; Mohammed N; Bradley J; Drammeh NF; Bah A; Masunaga Y; Achan J; Muela Ribera J; Yeung S; Balen J; Peeters Grietens K; D'Alessandro U
    Malar J; 2021 Jun; 20(1):253. PubMed ID: 34098984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the operational challenges in implementing reactive screen-and-treat and implications of reactive case detection strategies for malaria elimination in a region of low transmission in southern Zambia.
    Searle KM; Hamapumbu H; Lubinda J; Shields TM; Pinchoff J; Kobayashi T; Stevenson JC; Bridges DJ; Larsen DA; Thuma PE; Moss WJ;
    Malar J; 2016 Aug; 15(1):412. PubMed ID: 27527347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso.
    Tiono AB; Ouédraogo A; Ogutu B; Diarra A; Coulibaly S; Gansané A; Sirima SB; O'Neil G; Mukhopadhyay A; Hamed K
    Malar J; 2013 Feb; 12():79. PubMed ID: 23442748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.
    Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Björkman A; Mårtensson A
    Clin Infect Dis; 2011 Apr; 52(7):873-82. PubMed ID: 21427394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.